Literature DB >> 11321475

Effects of emitted Qi on in vitro natural killer cell cytotoxic activity.

M S Lee1, H J Huh, H S Jang, C S Han, H Ryu, H T Chung.   

Abstract

The present study investigated the effects of Korean Qi-therapy, ChunSoo Energy Healing, on natural killer (NK) cell cytotoxicity in vitro depending on Qi-treatment time and the types of cells treated. NK cell cytotoxicity was assayed by measuring LDH release from tumor target cells (K562 cell lines). NK activity was significantly increased by emitted-Qi treatment of 30 sec duration. Three and 5 minutes of Qi projection created the greatest increase in NK cell activity when mixtures of NK cells and K562 cells were treated (1.81 and 2.12 fold for 4 hr culture; 1.54 and 1.36 for 16 hr culture, respectively). NK cell activity increased significantly in Qi-treated K562 cells alone (1.13 fold, p<0.05) compared to control. These results are consistent with in vivo Qi-therapy on humans and suggests that emitted-Qi has an acute stimulatory effect on NK cell activity. This study provides direct scientific support that Qi as such may positively affect human cellular immunity.

Entities:  

Mesh:

Year:  2001        PMID: 11321475     DOI: 10.1142/S0192415X01000034

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  Growth inhibition of cultured human liver carcinoma cells by Ki-energy (life-energy): scientific evidence for Ki-effects on cancer cells.

Authors:  S Tsuyoshi Ohnishi; Tomoko Ohnishi; Kozo Nishino; Yoshinori Tsurusaki; Masayoshi Yamaguchi
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

2.  The effect of spiritual healing on in vitro tumour cell proliferation and viability--an experimental study.

Authors:  R Zachariae; L Højgaard; C Zachariae; M Vaeth; B Bang; L Skov
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

3.  Qigong ameliorates symptoms of chronic fatigue: a pilot uncontrolled study.

Authors:  Naropa J Mike Craske; Warren Turner; Joseph Zammit-Maempe; Myeong Soo Lee
Journal:  Evid Based Complement Alternat Med       Date:  2007-08-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.